| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-07 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
| mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-06 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |